We use cookies for a better user experience. Read our Privacy Policy

I Agree

Drug Eluting Balloon Market

Drug Eluting Balloon Market (Product - Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon; Drug Coating Technology - Paccocath, FreePac, TransPax, EnduraCoat) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Drug-eluting balloons refer to semi-compliant angioplasty balloons that are coated with anti-proliferative medications and are dispersed in the walls of blood arteries following balloon inflation, which is typically done at minimal pressures. These balloons greatly reduce cellularity and remove the need for repeated vascularization. The increasing vascular disease rates, increased product advancements, and rising elderly population are all contributing to increasing demand for the drug-eluting balloon in the healthcare industry. However, the global drug eluting balloon market is predicted to develop slowly owing to the high cost of processes and goods, as well as tight regulatory rules.

Increasing Initiatives from Government and Private Players to Drives Sales Opportunities in the Market

Over the last decade, the healthcare infrastructure has seen significant changes as technology has advanced and healthcare research has exploded. Some of the causes driving demand for drug eluting balloon catheters are increasing incidences of obesity, an aging population, and a rise in occurrence of coronary artery disease. Stents that are utilized with a balloon catheter are referred to as balloon expandable stents, as opposed to self-expandable stents, which are often composed of nitinol alloy.

The global drug eluting balloon market is also benefiting from the increasing adoption of angioplasty balloons for patients who do not gain from percutaneous coronary intervention (PCI). Governments and other organizations are increasingly supporting research and providing financing to further develop drug eluting balloon catheters.

drug eluting balloons market

Drug eluting devices are used to lessen the incidence of restenosis and are most commonly connected with cardiac problems. Over the next 10 years, the market for peripheral drug-coated balloon catheters is expected to expand at a stable growth rate. As the benefits of drug-eluting balloon catheters are discovered and treatments become more inexpensive, the use of these catheters for peripheral artery operations is expected to rise.

Demand for coronary artery disease drug eluting balloon catheters is expected to account for over 80% of market share when it comes to value in the indication segment. Despite a small market share, the demand for drug-eluting balloon catheters for peripheral vascular disease is expected to grow at a stable CAGR in the years to come. With additional angioplasty balloons being studied and manufactured, sales of peripheral drug-coated balloon catheters are expected to rise as well.

Cardiovascular illnesses are a serious public-health concern. Peripheral artery disease (PAD) is a prevalent kind of peripheral vascular disease that affects persons over the age of 65 years. PAD causes the walls of arteries to thin, slowing blood flow. Although it most usually affects the peripheral areas, it can also damage the arteries that bring blood from the head to the heart, kidneys, and stomach. Given the rising prevalence of cardiovascular illnesses, it's critical to comprehend the elements that influence the extent of the diseases and the effective treatment choices available. A number of governmental and private players are making serious efforts through various initiatives in reducing the prevalence of cardiovascular disease. Governments  as well as physicians and in industrialized nations have begun to inform the common people about PAD.

Every September, medical device firms, doctors, payers, and health care providers in the U.S. commemorate 'PAD Awareness Month.' During the awareness initiative, they strive to inform people about the ill effects of PAD and how to manage it. Several government agencies are funding research groups to help them produce drug-eluting balloons that are more successful in treating cardiovascular disorders. In the forthcoming years, this is anticipated to boost the global drug eluting balloon market.

North America and Asia Pacific to Lead the Market due to High Prevalence of Cardiovascular Illnesses

North America region is expected to account for a prominent share in the global drug eluting balloon market. High rate of treatment as well as diagnosis of cardiovascular illnesses and increasing spending on healthcare is anticipated to augur well for the drug eluting balloon market in North America. Besides, greater penetration of innovative products along with favorable reimbursement policies is expected to drive sales growth in the regional market.

However, the expiration of TPT reimbursement on medication eluting balloons in December 2017 and ' tight regulatory system in the U.S. are expected to limit the drug eluting balloon market's growth in North America over the next two to three years. Due to the growing senior population, need for higher quality of care, and rise in the prevalence of cardiovascular illnesses in the area, the drug eluting balloon market in Asia Pacific is expected to provide substantial potential throughout the projected period.

The global drug eluting balloon market has been segmented as follows:

Product

  • Coronary Drug Eluting Balloon
  • Peripheral Drug Eluting Balloon
  • Others

Technology

 

  • Paccocath
  • FreePac
  • TransPax
  • EnduraCoat
  • Others

End-user

  • Hospitals and Ambulatory Surgery Centers
  • CATH Labs
  • Others

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa
Drug Eluting Balloon Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of drug eluting balloon market?

The global drug eluting balloon market was worth US$ 420 Mn and is projected to reach a value of US$ 1800 Mn by the end of 2026

What is the anticipated CAGR of the drug eluting balloon market in the forecast period?

Drug eluting balloon market is anticipated to grow at a CAGR of 18% during the forecast period

Which region is expected to project the highest market share in the global drug eluting balloon market?

North America accounted for a major share of the global drug eluting balloon market

What are the key driving factors for the growth of the drug eluting balloon market?

Drug eluting balloon market is driven by increasing incidences of obesity, an aging population, and a rise in occurrence of coronary artery disease

Who are the key players in the global drug eluting balloon market?

Key players in the global drug eluting balloon market include Medtronic, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Terumo Corporation, Surmodics, Inc, and Biotronik

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Drug Eluting Balloon Market

4. Market Overview
     4.1. Introduction
            4.1.1. Product Type Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunities
     4.4. Global Drug Eluting Balloon Market Analysis and Forecast, 2016–2026
            4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook
     5.1. Reimbursement Scenario
     5.2. Cardiovascular Disease Prevalence
     5.3. Key Mergers & Acquisitions 
     5.4. Key Market Trends

6. Global Drug Eluting Balloon Market Analysis and Forecast, by Product Type 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Market Value Forecast, by Product Type, 2016–2026
            6.3.1. Coronary Drug Eluting Balloon
            6.3.2. Peripheral Drug Eluting Balloon 
            6.3.3 Others
     6.4. Market Attractiveness, by Product Type

7. Global Drug-Eluting Balloon Market Analysis and Forecast, by Drug Coating Technology 
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Market Value Forecast, by Drug Coating Technology, 2016–2026
            7.3.1. Paccocath
            7.3.2. FreePac
            7.3.3. TransPax
            7.3.4. EnduraCoat
            7.3.5. Others
     7.4. Market Attractiveness, by Drug Coating Technology

8. Global Drug Eluting Balloon Market Analysis and Forecast, by End-user 
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Market Value Forecast, by End-user, 2016–2026
            8.3.1. Hospitals & Ambulatory Surgical Centers 
            8.3.2. Cath Labs 
            8.3.3. Others
     8.4. Market Attractiveness, by End-user

9. Global Drug Eluting Balloon Market Analysis and Forecast, by Region
     9.1. Key Findings
     9.2. Market Value Forecast, by Region
            9.2.1. North America 
            9.2.2. Europe 
            9.2.3. Asia Pacific 
            9.2.4. Latin America 
            9.2.5. Middle East & Africa 
     9.3. Market Attractiveness, by Country/Region

10. North America Drug Eluting Balloon Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
     10.2. Market Value Forecast, by Product Type, 2016–2026
            10.2.1. Coronary Drug Eluting Balloon
            10.2.2. Peripheral Drug Eluting Balloon
            10.2.3. Others
     10.3. Market Value Forecast, by Drug Coating Technology, 2016–2026
            10.3.1. Paccocath
            10.3.2. FreePac 
            10.3.3. TransPax
            10.3.4. EnduraCoat 
            10.3.5. Others
     10.4. Market Value Forecast, by End-user, 2016–2026
            10.4.1. Hospitals & Ambulatory Surgical Centers
            10.4.2. Cath Labs 
            10.4.3. Others
     10.5. Market Value Forecast, by Country, 2016–2026
            10.5.1. U.S.
            10.5.2. Canada
     10.6. Market Attractiveness Analysis 
            10.6.1. By Product Type 
            10.6.2. By Drug Coating Technology
            10.6.3. By End-user 
            10.6.4. By Country

11. Europe Drug Eluting Balloon Market Analysis and Forecast
     11.1.Introduction
            11.1.1. Key Findings
     11.2.Market Value Forecast, by Product Type, 2016–2026
            11.2.1. Coronary Drug Eluting Balloon
            11.2.2. Peripheral Drug Eluting Balloon
            11.2.3 Others
     11.3.Market Value Forecast, by Drug Coating Technology, 2016–2026
            11.3.1. Paccocath
            11.3.2. FreePac 
            11.3.3. TransPax
            11.3.4. EnduraCoat 
            11.3.5. Others
     11.4.Market Value Forecast, by End-user, 2016–2026
            11.4.1. Hospitals & Ambulatory Surgical Centers
            11.4.2. Cath Labs 
            11.4.3. Others
     11.5.Market Value Forecast, by Country/Sub-region, 2016–2026
            11.5.1. Germany
            11.5.2. U.K.
            11.5.3. France
            11.5.4. Italy
            11.5.5. Spain
            11.5.6. Rest of Europe
     11.6.Market Attractiveness Analysis 
            11.6.1. By Product Type 
            11.6.2. By Drug Coating Technology
            11.6.3. By End-user 
            11.6.4. By Country/Sub-region

12. Asia Pacific Drug Eluting Balloon Market Analysis and Forecast
     12.1.Introduction
            12.1.1. Key Findings
     12.2.Market Value Forecast, by Product Type, 2016–2026
            12.2.1. Coronary Drug Eluting Balloon
            12.2.2. Peripheral Drug Eluting Balloon
            12.2.3. Others
     12.3.Market Value Forecast, by Drug Coating Technology, 2016–2026
            12.3.1. Paccocath
            12.3.2. FreePac 
            12.3.3. TransPax
            12.3.4. EnduraCoat 
            12.3.5. Others
     12.4.Market Value Forecast, by End-user, 2016–2026
            12.4.1. Hospitals & Ambulatory Surgical Centers
            12.4.2. Cath Labs 
            12.4.3. Others
     12.5.Market Value Forecast, by Country/Sub-region, 2016–2026
            12.5.1. China
            12.5.2. Japan
            12.5.3. India
            12.5.4. Australia & New Zealand
            12.5.5. Rest of Asia Pacific
     12.6.Market Attractiveness Analysis 
            12.6.1. By Product Type 
            12.6.2. By Drug Coating Technology
            12.6.3. By End-user 
            12.6.4. By Country

13. Latin America Drug Eluting Balloon Market Analysis and Forecast
     13.1.Introduction
            13.1.1. Key Findings
     13.2.Market Value Forecast, by Product Type, 2016–2026
            13.2.1. Coronary Drug Eluting Balloon
            13.2.2. Peripheral Drug Eluting Balloon
            13.2.3 Others
     13.3.Market Value Forecast, by Drug Coating Technology, 2016–2026
            13.3.1. Paccocath
            13.3.2. FreePac 
            13.3.3. TransPax
            13.3.4. EnduraCoat 
            13.3.5. Others
     13.4.Market Value Forecast, by End-user, 2016–2026
            13.4.1. Hospitals & Ambulatory Surgical Centers
            13.4.2. Cath Labs 
            13.4.3. Others
     13.5.Market Value Forecast, by Country/Sub-region, 2016–2026
            13.5.1. Brazil
            13.5.2. Mexico
            13.5.3. Rest of Latin America
     13.6.Market Attractiveness Analysis 
            13.6.1. By Product Type 
            13.6.2. By Drug Coating Technology
            13.6.3. By End-user 
            13.6.4. By Country/Sub-region

14. Middle East & Africa Drug-Eluting Balloon Market Analysis and Forecast
     14.1.Introduction
            14.1.1. Key Findings
     14.2.Market Value Forecast, by Product Type, 2016–2026
            14.2.1. Coronary Drug Eluting Balloon
            14.2.2. Peripheral Drug Eluting Balloon
            14.2.3 Others
     14.3.Market Value Forecast, by Drug Coating Technology, 2016–2026
            14.3.1. Paccocath
            14.3.2. FreePac 
            14.3.3. TransPax
            14.3.4. EnduraCoat 
            14.3.5. Others
     14.4.Market Value Forecast, by End-user, 2016–2026
            14.4.1. Hospitals & Ambulatory Surgical Centers
            14.4.2. Cath Labs 
            14.4.3. Others
     14.5.Market Value Forecast, by Country/Sub-region, 2016–2026
            14.5.1. GCC Countries
            14.5.2. South Africa
            14.5.3. Israel
            14.5.4. Rest of Middle East & Africa 
     14.6.Market Attractiveness Analysis 
            14.6.1. By Product Type 
            14.6.2. By Drug Coating Technology
            14.6.3. By End-user 
            14.6.4. By Country/Sub-region

15. Competition Landscape
     15.1.Market Player – Competition Matrix (by Tier and Size of companies)
     15.2.Market Share Analysis, by Company (2017)
     15.3. Competitive Business Strategies
     15.4. Company Profiles
            15.4.1. Bayer AG
                      15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                      15.4.1.2. Product Portfolio
                      15.4.1.3. SWOT Analysis
                      15.4.1.4. Strategic Overview
                      15.4.1.5. Financial Overview
            15.4.2. Medtronic
                      15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                      15.4.2.2. Product Portfolio
                      15.4.2.3. SWOT Analysis
                      15.4.2.4. Strategic Overview
                      15.4.2.5. Financial Overview
            15.4.3. B. Braun Melsungen AG
                      15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                      15.4.3.2. Product Portfolio
                      15.4.3.3. SWOT Analysis
                      15.4.3.4. Strategic Overview
                      15.4.3.5. Financial Overview
            15.4.4. Cook Medical, Inc.
                      15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                      15.4.4.2. Product Portfolio
                      15.4.4.3. SWOT Analysis
                      15.4.4.4. Strategic Overview
                      15.4.4.5. Financial Overview
            15.4.5. Boston Scientific Corporation
                      15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                      15.4.5.2. Product Portfolio
                      15.4.5.3. SWOT Analysis
                      15.4.5.4. Strategic Overview
                      15.4.5.5. Financial Overview
            15.4.6. Becton, Dickinson and Company
                      15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                      15.4.6.2. Product Portfolio
                      15.4.6.3. SWOT Analysis
                      15.4.6.4. Strategic Overview
                      15.4.6.5. Financial Overview
            15.4.7. EuroCor
                      15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                      15.4.7.2. Product Portfolio
                      15.4.7.3. SWOT Analysis
                      15.4.7.4. Strategic Overview
                      15.4.7.5. Financial Overview
            15.4.8. Terumo Corporation
                      15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                      15.4.8.2. Product Portfolio
                      15.4.8.3. SWOT Analysis
                      15.4.8.4. Strategic Overview
                      15.4.8.5. Financial Overview
            15.4.9. Koninklijke Philips N.V
                      15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                      15.4.9.2. Product Portfolio
                      15.4.9.3. SWOT Analysis
                      15.4.9.4. Strategic Overview
                      15.4.9.5. Financial Overview
            15.4.10. Other Prominent Players
                      15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                      15.4.10.2. Product Portfolio
                      15.4.10.3. SWOT Analysis
                      15.4.10.4. Strategic Overview
                      15.4.10.5. Financial Overview

List of Tables

Table 1: Key Mergers and Acquisitions on Drug Eluting Balloon
Table 2: Snapshot of Ongoing Research on Drug Eluting Balloon
Table 3: Recent Patents on Drug Eluting Balloon
Table 4: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
Table 5: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Drug Coating Technology, 2016-2026
Table 6: Global Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016-2026
Table 7: Global Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Region, 2016-2026
Table 8: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 9: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 10: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016–2026
Table 11: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 12: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 13: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 14: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016–2026
Table 15: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 16: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
Table 17: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
Table 18: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016-2026
Table 19: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016-2026
Table 20: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
Table 21: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
Table 22: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016-2026
Table 23: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016-2026
Table 24: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region,
Table 25: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 26: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016–2026
Table 27: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016–2026

List of Figures

 

Figure 1: Global Drug Eluting Balloon Market Size (US$ Mn) and Distribution, by Geography, 2017 and 2026

Figure 2: Global Drug Eluting Balloon Market (US$ Mn), by Key Segment, 2017

Figure 3: Global Drug Eluting Balloon Market (US$ Mn), by Key Segment and Market Share (%), 2017

Figure 4: Global Drug Eluting Balloon Market (US$ Mn), by Market Share (%), 2017

Figure 5: Global Drug Eluting Balloon Market (US$ Mn), by Region (%), 2017

Figure 6: Global Drug Eluting Balloon Market Opportunity Map, by Product Type

Figure 7: Global Drug Eluting Balloon Market Opportunity Map, by Drug Coating Technology

Figure 8: Global Drug Eluting Balloon Market Opportunity Map, by End-user

Figure 9: Key Industry Evolution/Developments

Figure 10: Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026

Figure 11: Global Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026

Figure 12: Global Drug Eluting Balloon Market Attractiveness, by Product Type, 2018-2026

Figure 13: Coronary Drug Eluting Balloon Segment

Figure 14: Peripheral Drug Eluting Balloon Segment

Figure 15: Others Segment

Figure 16: Global Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026

Figure 17: Global Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018-2026

Figure 18: Paccocath Segment

Figure 19: TransPax Segment

Figure 20: FreePac Segment

Figure 21: EnduraCoat Segment

Figure 22: Others Segment

Figure 23: Global Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026

Figure 24: Global Drug Eluting Balloon Market Attractiveness, End-user 2018-2026

Figure 25: Hospitals and ASCs Segment

Figure 26: CATH Labs segment

Figure 27: Others Segment

Figure 28: Global Drug Eluting Balloon Market Value Share, by Region, 2017 and 2026

Figure 29: Global Drug Eluting Balloon Market Attractiveness, Region

Figure 30: North America Drug Eluting Balloons Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

Figure 31: North America Drug Eluting Balloon Market Value Share, by Country, 2017 and 2026

Figure 32: North America Drug Eluting Balloon Market Attractiveness, by Country, 2018–2026

Figure 33: North America Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026

Figure 34: North America Drug Eluting Balloon Market Attractiveness, by Product Type, 2018–2026

Figure 35: North America Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026

Figure 36: North America Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018–2026

Figure 37: North America Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026

Figure 38: North America Drug Eluting Balloon Market Attractiveness, by End-user, 2018–2026

Figure 39: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

Figure 40: Europe Drug Eluting Balloon Market Value Share, by Country/Sub-region, 2017 and 2026

Figure 41: Europe Drug Eluting Balloon Market Attractiveness, by Country/Sub-region, 2018–2026

Figure 42: Europe Drug Eluting Balloons Market Value Share, by Product Type, 2017 and 2026

Figure 43: Europe Drug Eluting Balloon Market Attractiveness, by Product Type, 2018–2026

Figure 44: Europe Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026

Figure 45: Europe Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018–2026

Figure 46: Europe Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026

Figure 47: Europe Drug Eluting Balloon Market Attractiveness, by End-user, 2018–2026

Figure 48: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026

Figure 49: Asia Pacific Drug Eluting Balloon Market Value Share, by Country/Sub-region, 2017 and 2026

Figure 50: Asia Pacific Drug Eluting Balloon Market Attractiveness, by Country/Sub-region, 2018-2026

Figure 51: Asia Pacific Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026

Figure 52: Asia Pacific Drug Eluting Balloon Market Attractiveness, by Product Type, 2018-2026

Figure 53: Asia Pacific Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026

Figure 54: Asia Pacific Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018-2026

Figure 55: Asia Pacific Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026

Figure 56: Asia Pacific Drug Eluting Balloon Market Attractiveness, by End-user, 2018-2026

Figure 57: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026

Figure 58: Latin America Drug Eluting Balloon Market Value Share, by Country/Sub-region, 2017 and 2026

Figure 59: Latin America Drug Eluting Balloon Market Attractiveness, by Country/Sub-region, 2018-2026

Figure 60: Latin America Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026

Figure 61: Latin America Drug Eluting Balloon Market Attractiveness, by Product Type, 2018-2026

Figure 62: Latin America Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026

Figure 63: Latin America Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018-2026

Figure 64: Latin America Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026

Figure 65: Latin America Drug Eluting Balloon Market Attractiveness, by End-user, 2018-2026

Figure 66: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

Figure 67: Middle East & Africa Drug Eluting Balloon Market Value Share, by Country/Sub-region, 2017 and 2026

Figure 68: Middle East & Africa Drug Eluting Balloon Market Attractiveness, by Country/Sub-region, 2018–2026

Figure 69: Middle East & Africa Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026

Figure 70: Middle East & Africa Drug Eluting Balloon Market Attractiveness, by Product Type, 2018–2026

Figure 71: Middle East & Africa Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026

Figure 72: Middle East & Africa Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018–2026

Figure 73: Middle East & Africa Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026

Figure 74: Middle East & Africa Drug Eluting Balloon Market Attractiveness, by End-user, 2018–2026

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

168

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved